REGISTERED NUMBER: |
UNAUDITED FINANCIAL STATEMENTS |
FOR THE PERIOD |
1 JANUARY 2024 TO 31 JANUARY 2025 |
FOR |
INTENSICHEM GROUP LIMITED |
REGISTERED NUMBER: |
UNAUDITED FINANCIAL STATEMENTS |
FOR THE PERIOD |
1 JANUARY 2024 TO 31 JANUARY 2025 |
FOR |
INTENSICHEM GROUP LIMITED |
INTENSICHEM GROUP LIMITED (REGISTERED NUMBER: 07816557) |
CONTENTS OF THE FINANCIAL STATEMENTS |
FOR THE PERIOD 1 JANUARY 2024 TO 31 JANUARY 2025 |
Page |
Company Information | 1 |
Balance Sheet | 2 |
Notes to the Financial Statements | 4 |
INTENSICHEM GROUP LIMITED |
COMPANY INFORMATION |
FOR THE PERIOD 1 JANUARY 2024 TO 31 JANUARY 2025 |
DIRECTORS: |
SECRETARY: |
REGISTERED OFFICE: |
REGISTERED NUMBER: |
ACCOUNTANTS: |
Chartered Accountants |
1 Langley Court |
Pyle Street |
Newport |
Isle of Wight |
PO30 1LA |
INTENSICHEM GROUP LIMITED (REGISTERED NUMBER: 07816557) |
BALANCE SHEET |
31 JANUARY 2025 |
2025 | 2023 |
Notes | £ | £ | £ | £ |
FIXED ASSETS |
Intangible assets | 4 |
Tangible assets | 5 |
Investments | 6 |
CURRENT ASSETS |
Debtors | 7 |
Cash at bank |
CREDITORS |
Amounts falling due within one year | 8 |
NET CURRENT ASSETS |
TOTAL ASSETS LESS CURRENT LIABILITIES |
CAPITAL AND RESERVES |
Called up share capital | 9 |
Share premium |
Retained earnings | ( |
) | ( |
) |
SHAREHOLDERS' FUNDS |
The directors acknowledge their responsibilities for: |
(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company. |
INTENSICHEM GROUP LIMITED (REGISTERED NUMBER: 07816557) |
BALANCE SHEET - continued |
31 JANUARY 2025 |
In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered. |
The financial statements were approved by the Board of Directors and authorised for issue on |
INTENSICHEM GROUP LIMITED (REGISTERED NUMBER: 07816557) |
NOTES TO THE FINANCIAL STATEMENTS |
FOR THE PERIOD 1 JANUARY 2024 TO 31 JANUARY 2025 |
1. | STATUTORY INFORMATION |
Intensichem Group Limited is a |
2. | ACCOUNTING POLICIES |
Basis of preparing the financial statements |
Intangible assets |
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses. |
Tangible fixed assets |
Plant and machinery | - |
Computer equipment | - |
Investments in subsidiaries |
Investments in subsidiary undertakings are recognised at cost. |
3. | EMPLOYEES AND DIRECTORS |
The average number of employees during the period was |
4. | INTANGIBLE FIXED ASSETS |
Patents and |
licences |
£ |
COST |
At 1 January 2024 |
Additions |
At 31 January 2025 |
AMORTISATION |
At 1 January 2024 |
Amortisation for period |
At 31 January 2025 |
NET BOOK VALUE |
At 31 January 2025 |
At 31 December 2023 |
INTENSICHEM GROUP LIMITED (REGISTERED NUMBER: 07816557) |
NOTES TO THE FINANCIAL STATEMENTS - continued |
FOR THE PERIOD 1 JANUARY 2024 TO 31 JANUARY 2025 |
4. | INTANGIBLE FIXED ASSETS - continued |
The intangible asset is the granted United Kingdom patent number 10960373, which relates to the invention of a continuous flow hydrogenation process and process apparatus. During February 2025 the company granted a licence to Intensichem Solutions Limited, a company controlled by Oliver Tames and John Tiley, allowing that company to use the said patent in return for a royalty of 30%, payable to the company, of the net sales value deriving from all patent exploitative products, sold or otherwise supplied for money or money's worth. |
This licence replaced a similar agreement between the company and Intensichem Limited, a wholly owned subsidiary, which subsequent to the period end, during February 2025, entered into liquidation. |
5. | TANGIBLE FIXED ASSETS |
Plant and | Computer |
machinery | equipment | Totals |
£ | £ | £ |
COST |
At 1 January 2024 |
and 31 January 2025 |
DEPRECIATION |
At 1 January 2024 |
Charge for period |
At 31 January 2025 |
NET BOOK VALUE |
At 31 January 2025 |
At 31 December 2023 |
6. | FIXED ASSET INVESTMENTS |
Shares in |
group |
undertakings |
£ |
COST |
At 1 January 2024 |
Disposals | ( |
) |
At 31 January 2025 |
NET BOOK VALUE |
At 31 January 2025 |
At 31 December 2023 |
INTENSICHEM GROUP LIMITED (REGISTERED NUMBER: 07816557) |
NOTES TO THE FINANCIAL STATEMENTS - continued |
FOR THE PERIOD 1 JANUARY 2024 TO 31 JANUARY 2025 |
6. | FIXED ASSET INVESTMENTS - continued |
The company's investments at the Balance Sheet date in the share capital of companies include the following: |
Registered office: 4 Kings Row, Armstrong Road, Maidstone, Kent. ME15 6AQ |
Nature of business: |
% |
Class of shares: | holding |
£ | £ |
Aggregate capital and reserves | ( |
) | ( |
) |
Loss for the period | ( |
) | ( |
) |
The company's wholly owned subsidiary, Intensichem Limited ceased trading on 31st January 2025 and subsequent to the period end, during February 2025, it entered liquidation. The directors consider that the company's investment in Intensichem Limited has no value and it has been written off in these accounts. |
7. | DEBTORS |
2025 | 2023 |
£ | £ |
Amounts falling due within one year: |
Other debtors |
Amounts falling due after more than one year: |
Amounts owed by group undertakings |
Aggregate amounts |
The amount previously shown as due after more than year, related to an amount owed to the company by the wholly subsidiary, Intensichem Limited. Intensichem Limited ceased trading on 31st January 2025 and has subsequently entered liquidation, the directors consider that the balance owed to the company is irrecoverable and it has been written off in these accounts. |
8. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
2025 | 2023 |
£ | £ |
Other creditors |
Other creditors comprises of a company credit card balance. |
INTENSICHEM GROUP LIMITED (REGISTERED NUMBER: 07816557) |
NOTES TO THE FINANCIAL STATEMENTS - continued |
FOR THE PERIOD 1 JANUARY 2024 TO 31 JANUARY 2025 |
9. | CALLED UP SHARE CAPITAL |
Allotted, issued and fully paid: |
Number: | Class: | Nominal | 2025 | 2023 |
value: | £ | £ |
Ordinary A | £1 | 3,146 | 3,146 |
Ordinary B | £1 | 7,934 | 7,934 |
Ordinary C | £1 | 786 | 786 |
Ordinary D | £1 | 786 | 786 |
Ordinary E | £1 | 22,231 | 22,231 |
711 | Ordinary F | £1 | 711 | 711 |
35,594 | 35,594 |
10. | RELATED PARTY DISCLOSURES |
During the period Intensichem Limited, a wholly owned subsidiary company made payments on behalf of the company. These transactions are recorded through an intercompany account and, as at the balance sheet date, the amount owed by Intensichem Limited was £308,260 (YE Dec-23: £337,797). |
Intensichem Limited ceased trading on 31st January 2025 and subsequent to the period end, during February 2025, it entered liquidation. The directors consider that the balance due from Intensichem Limited is irrecoverable and has been written off in these accounts. |
Intensichem Limited, a wholly owned subsidiary, benefited from a licence granted by the company, under United Kingdom Patent No 10960373, relating to the invention of a continuous flow hydrogenation process and process apparatus. The licence permitted Intensichem Limited to use the said patent in return for a royalty of 30%, payable to the company, of the net sales value deriving from all patent exploitative products, sold or otherwise supplied for money or money's worth. Intensichem Limited's use of the patent has remained in the research and development phase, and to date no such income has arisen. |
Subsequent to the period end, during February 2025, Intensichem Limited entered liquidation, and the company has granted a similar licence to Intensichem Solutions Limited, a company controlled by Oliver Tames and John Tiley. |
During the period, Mackenzies Chartered Accountants provided services to the group and these are disclosed fully in the notes of the subsidiary company, Intensichem Limited. One of the directors of Mackenzies holds a 2.5% interest in the share capital of the company. |
11. | ULTIMATE CONTROLLING PARTY |
No individual is the ultimate controlling party. The shareholders among themselves hold the entire share capital of the company. |